Faron Pharmaceuticals Oy (HEL: FARON)

Faron Pharmaceuticals Oy Statistics

Total Valuation

Faron Pharmaceuticals Oy has a market cap or net worth of EUR 259.36 million. The enterprise value is 241.67 million.

Market Cap	259.36M
Enterprise Value	241.67M

Important Dates

The last earnings date was Wednesday, December 4, 2024.

Earnings Date	Dec 4, 2024
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+14.45%
Shares Change (QoQ)	+4.96%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	73.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	885.18
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-7.65
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.45, with a Debt / Equity ratio of 9.23.

Current Ratio	1.45
Quick Ratio	1.28
Debt / Equity	9.23
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-4.83

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-70.00%
Return on Capital (ROIC)	-186.82%
Revenue Per Employee	n/a
Profits Per Employee	-929,676
Employee Count	34
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -32.63% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-32.63%
50-Day Moving Average	2.06
200-Day Moving Average	1.99
Relative Strength Index (RSI)	70.44
Average Volume (20 Days)	276,976

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-27.05M
Pretax Income	-31.56M
Net Income	-31.61M
EBITDA	-26.87M
EBIT	-27.05M
Earnings Per Share (EPS)	-0.46

Balance Sheet

The company has 29.98 million in cash and 12.72 million in debt, giving a net cash position of 17.26 million.

Cash & Cash Equivalents	29.98M
Total Debt	12.72M
Net Cash	17.26M
Net Cash Per Share	n/a
Equity (Book Value)	1.38M
Book Value Per Share	0.01
Working Capital	10.47M

Cash Flow

Operating Cash Flow	-20.16M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Faron Pharmaceuticals Oy does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.45%
Shareholder Yield	-14.45%
Earnings Yield	-18.09%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a